EP2707003
Kristölluð sölt af 84S,4AS,5AR,12AS)-4-dímetýlamínó-3,10,12,12A-tetrahýdroxý-7-[(metoxý(metýl)amínó)-metýl]-1,11-díoxó-1,4,4A,5,5A,6,11,12A-oktahýdró-naftasen-2-karboxýlsýruamíð og aðferðir við að nota þau
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.5.2012EP published:
1.5.2019EP application number:
12782600.6
EP translation filed:
16.7.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
13.5.2032Expiry date:
13.5.2025
Title:
CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME
Timeline
Today
14.5.2012EP application
1.5.2019EP Publication
16.7.2019Translation submitted
15.8.2019Registration published
13.5.2025Expires
Owner
Name:
Paratek Pharmaceuticals, Inc.Address:
75 Park Plaza, 02116, Boston, MA, US
Name:
Allergan Pharmaceuticals International LimitedAddress:
Clonshaugh Industrial Estate, Coolock, 17, Dublin, IE
Inventor
Name:
COULTER, CatherineAddress:
BallymenaCo Antrim, IE
Name:
JOHNSTON, Sean, M.Address:
DoylestownPA, US
Name:
SEYEDI, FarzanehAddress:
MansfieldMA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161485179 PDate:
12.5.2011Country:
US
Classification
Categories:
A61K 31/65, C07C 237/26
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 24.7.2019
Expires: 13.5.2020
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 20.4.2020
Expires: 13.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.4.2021
Expires: 13.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 3.5.2022
Expires: 13.5.2023
Payer: Patice ehf.
Number: 12
Paid: 31.10.2023
Expires: 13.5.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 2.5.2024
Expires: 13.5.2025
Payer: Árnason Faktor ehf.